)
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
The competitive intensity is high between brands, at a time when volume growth in the domestic pharma market is on a slow lane
The diagnostic player has also taken price hikes in the range of 4-5 percent in the last three years
M&M Board had approved a stake buy of up to 4.5 per cent in RBL Bank
The board has recommended a dividend of Rs 16.25 per share
Seek a separate 'Medical Devices Act' distinct from the drug regulations Bill
Sun Pharma's stock ended flat at Rs 1140.85 on the BSE
Singapore investment firm to hold 1.49-2.97% stake in EV business
Juneja also highlighted a 43 per cent YoY increase in Ebitda as a positive outcome of the company's previous initiatives to improve profitability
Maruti says it wants to have multiple powertrain production at multiple locations under single control
Maruti will take over EV production at Gujarat site, replacing Suzuki Motor Corp
Batches manufactured on and after August 1 will have QR codes printed on the packaging of the selected 300 brands
It is the fastest growing segment in IPM with a 25% CAGR
Boston, Massachusetts-based TA Associates is selling its 47 per cent stake in Indira IVF
Some members of the promoter group had pledged certain shares of Wockhardt with Guardian Finance to avail loan
Mumbai doctors say that in the last one or two weeks there has been a 20-25 per cent surge in such cases, and most of the patients are children
Cipla shares closed 9.6 per cent up on Thursday to Rs. 1,175
As of July 27, Cipla's market cap stands at Rs 94572 crore
Acquisition of Stelis facility saves $15 million in capex in FY24
Company says it may consider further investment in the bank to raise its holding up to 9.9%
With cash surplus of Rs 4980 crore, pharma major looking at inorganic opportunities